Related Experiment Video
Updated: Apr 18, 2026
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Max Wilms and his tumor
14771 Tradewinds, Sanibel, FL, 33957.
Abstract:
The most common cancer of the kidney in infants and children is named for Max Wilms, a German surgeon. How did this eponym come about? There were excellent reviews of this lesion before Wilms, a second year surgical assistant, published "Die Mischgeschwulste Der Niere" or The Mixed Tumors of the Kidney in 1899. At thirty two years of age, he demonstrated a masterful knowledge of pathology and embryology. Wilms' career was cut short when he became septic after operating on a prisoner of war during WWI. The survival rate for children with Wilms tumor was dismal until William Ladd, at the Boston Children's hospital introduced rational surgical treatment. By mid century, Robert Gross achieved a 47% survival rate with surgery combined with postoperative radiation. Sydney Farber treated Wilms tumors with Actinomycin-d and opened the door to cancer chemotherapy. With protocols developed by the National Wilms Tumor Study Group, the survival rate of children with Wilms tumors reached 90% by the end of the twentieth century.
Insights
Wilms tumor, a common pediatric kidney cancer, is named after surgeon Max Wilms. Advances in surgical treatment, radiation, and chemotherapy have dramatically improved survival rates for children with this disease.
Area of Science:
- Pediatric Oncology
- Nephrology
- Medical History
Background:
- Wilms tumor, the most frequent kidney cancer in children, is eponymously named after German surgeon Max Wilms.
- Wilms' seminal 1899 publication, "Die Mischgeschwulste Der Niere" (The Mixed Tumors of the Kidney), showcased his early expertise in pathology and embryology.
Discussion:
- Early survival rates for Wilms tumor were poor, necessitating significant medical advancements.
- The introduction of rational surgical techniques by William Ladd marked a turning point in treatment.
- Subsequent integration of radiation therapy by Robert Gross and chemotherapy (Actinomycin-d) by Sydney Farber further improved outcomes.
Key Insights:
- The historical progression of Wilms tumor treatment highlights a collaborative effort across multiple medical disciplines.
- Max Wilms' early pathological descriptions laid foundational knowledge for understanding this pediatric malignancy.
- Key figures like Ladd, Gross, and Farber, alongside the National Wilms Tumor Study Group, were instrumental in developing effective treatment protocols.
Outlook:
- Continued research and refinement of treatment protocols are essential for further enhancing pediatric cancer survival rates.
- Understanding the historical trajectory of Wilms tumor management provides valuable insights for current and future pediatric cancer research.
- Multidisciplinary approaches and collaborative study groups remain critical for advancing the treatment of childhood cancers.
